195 related articles for article (PubMed ID: 34951571)
1. Sodium Tanshinone IIA Sulfonate Improves Adverse Ventricular Remodeling Post-MI by Reducing Myocardial Necrosis, Modulating Inflammation, and Promoting Angiogenesis.
Zhang B; Yu P; Su E; Jia J; Zhang C; Xie S; Huang Z; Dong Y; Ding J; Zou Y; Jiang H; Ge J
Curr Pharm Des; 2022; 28(9):751-759. PubMed ID: 34951571
[TBL] [Abstract][Full Text] [Related]
2. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.
Du Y; Ge Y; Xu Z; Aa N; Gu X; Meng H; Lin Z; Zhu D; Shi J; Zhuang R; Wu X; Wang X; Yang Z
Med Sci Monit; 2018 Dec; 24():8870-8877. PubMed ID: 30531686
[TBL] [Abstract][Full Text] [Related]
4. [Electroacupuncture improves long-term survival of myocardial infarction mice by promoting myocardial angiogenesis and inhibiting ventricular remodeling].
Zhang JJ; Xie CL; Yong Y; Chi H; Lu LY; Zou YH; Ruan WQ; Song JG
Zhen Ci Yan Jiu; 2022 Mar; 47(3):189-95. PubMed ID: 35319834
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of sodium tanshinone IIA sulfonate on cardiac function after myocardial infarction in mice.
Wu P; Du Y; Xu Z; Zhang S; Liu J; Aa N; Yang Z
Am J Transl Res; 2019; 11(1):351-360. PubMed ID: 30787992
[TBL] [Abstract][Full Text] [Related]
6. Total flavonoids from Anchusa italica Retz. Improve cardiac function and attenuate cardiac remodeling post myocardial infarction in mice.
Wang S; Zhao Y; Song J; Wang R; Gao L; Zhang L; Fang L; Lu Y; Du G
J Ethnopharmacol; 2020 Jul; 257():112887. PubMed ID: 32315737
[TBL] [Abstract][Full Text] [Related]
7. Sodium tanshinone IIA sulfonate attenuates cardiac dysfunction and improves survival of rats with cecal ligation and puncture-induced sepsis.
Meng ZJ; Wang C; Meng LT; Bao BH; Wu JH; Hu YQ
Chin J Nat Med; 2018 Nov; 16(11):846-855. PubMed ID: 30502766
[TBL] [Abstract][Full Text] [Related]
8. IL-6 knockout ameliorates myocardial remodeling after myocardial infarction by regulating activation of M2 macrophages and fibroblast cells.
Jing R; Long TY; Pan W; Li F; Xie QY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6283-6291. PubMed ID: 31364133
[TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway.
Pan W; Zhou G; Hu M; Li G; Zhang M; Yang H; Li K; Li J; Liu T; Wang Y; Jin J
BMC Cardiovasc Disord; 2024 Jan; 24(1):76. PubMed ID: 38281937
[TBL] [Abstract][Full Text] [Related]
10. KDM3A inhibition modulates macrophage polarization to aggravate post-MI injuries and accelerates adverse ventricular remodeling via an IRF4 signaling pathway.
Liu X; Chen J; Zhang B; Liu G; Zhao H; Hu Q
Cell Signal; 2019 Dec; 64():109415. PubMed ID: 31513837
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocyte A Disintegrin And Metalloproteinase 17 (ADAM17) Is Essential in Post-Myocardial Infarction Repair by Regulating Angiogenesis.
Fan D; Takawale A; Shen M; Wang W; Wang X; Basu R; Oudit GY; Kassiri Z
Circ Heart Fail; 2015 Sep; 8(5):970-9. PubMed ID: 26136458
[TBL] [Abstract][Full Text] [Related]
12. Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction.
Mao S; Vincent M; Chen M; Zhang M; Hinek A
Front Pharmacol; 2019; 10():779. PubMed ID: 31354493
[TBL] [Abstract][Full Text] [Related]
13. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
[TBL] [Abstract][Full Text] [Related]
14. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
15. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin octapeptide reduces myocardial fibrosis and improves cardiac remodeling in post myocardial infarction rats.
Wang C; Zhang C; Wu D; Guo L; Zhao F; Lv J; Fu L
Int J Biochem Cell Biol; 2020 Aug; 125():105793. PubMed ID: 32554056
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization.
Takamura M; Kurokawa K; Ootsuji H; Inoue O; Okada H; Nomura A; Kaneko S; Usui S
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28223437
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
Ren ZH; Tong YH; Xu W; Ma J; Chen Y
Phytomedicine; 2010 Mar; 17(3-4):212-8. PubMed ID: 19800776
[TBL] [Abstract][Full Text] [Related]
19. Sodium tanshinone IIA sulfonate prevents the adverse left ventricular remodelling: Focus on polymorphonuclear neutrophil-derived granule components.
Mao S; Taylor S; Chen Q; Zhang M; Hinek A
J Cell Mol Med; 2019 Jul; 23(7):4592-4600. PubMed ID: 31066232
[TBL] [Abstract][Full Text] [Related]
20. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
